Literature DB >> 29319623

B Cells in Transplantation of Rat, Mouse, and Man.

Jeffrey L Platt1, Marilia Cascalho1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29319623      PMCID: PMC5843468          DOI: 10.1097/TP.0000000000002051

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  14 in total

1.  B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.

Authors:  Hooman Noorchashm; Amy J Reed; Susan Y Rostami; Raha Mozaffari; Ghazal Zekavat; Brigitte Koeberlein; Andrew J Caton; Ali Naji
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.

Authors:  Carl Atkinson; Fei Qiao; Xiaofeng Yang; Peng Zhu; Nicholas Reaves; Liudmila Kulik; Martin Goddard; V Michael Holers; Stephen Tomlinson
Journal:  Circulation       Date:  2015-02-17       Impact factor: 29.690

3.  Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury.

Authors:  Melissa J Burne-Taney; Naoko Yokota-Ikeda; Hamid Rabb
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

4.  C3d regulates immune checkpoint blockade and enhances antitumor immunity.

Authors:  Jeffrey L Platt; Inês Silva; Samuel J Balin; Adam R Lefferts; Evan Farkash; Ted M Ross; Michael C Carroll; Marilia Cascalho
Journal:  JCI Insight       Date:  2017-05-04

Review 5.  Complement resistance of tumor cells: basal and induced mechanisms.

Authors:  K Jurianz; S Ziegler; H Garcia-Schüler; S Kraus; O Bohana-Kashtan; Z Fishelson; M Kirschfink
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

6.  Mouse strains with typical mammalian levels of complement activity.

Authors:  G L Ong; M J Mattes
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

7.  A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

Authors:  Ashley A Vo; Adriana Zeevi; Jua Choi; Kristen Cisneros; Mieko Toyoda; Joseph Kahwaji; Alice Peng; Rafael Villicana; Dechu Puliyanda; Nancy Reinsmoen; Mark Haas; Stanley C Jordan
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

8.  Complete B Cell Deficiency Reduces Allograft Inflammation and Intragraft Macrophages in a Rat Kidney Transplant Model.

Authors:  Sarah E Panzer; Nancy A Wilson; Bret M Verhoven; Ding Xiang; C Dustin Rubinstein; Robert R Redfield; Weixiong Zhong; Shannon R Reese
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

9.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

Authors:  M R Weiser; J P Williams; F D Moore; L Kobzik; M Ma; H B Hechtman; M C Carroll
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

10.  IgM in the kidney: a multiple personality disorder.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Kidney Int       Date:  2015-09       Impact factor: 10.612

View more
  1 in total

Review 1.  Non-canonical B cell functions in transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Hum Immunol       Date:  2019-04-10       Impact factor: 2.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.